Description
MATULANE (PROCARBAZINE) 50MG
First action · last action
2015-09-03 · 2017-09-12
Transactions
2
First transaction's obligation
$7,767
Base + all options value (sum of deltas)
$3,884
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-09-03+$7,767= $7,767
- Mod P000012017-09-12-$3,885= $3,883
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-09-03 | +$7,767 | $7,767 | MATULANE (PROCARBAZINE) 50MG |
| Mod P00001· CHANGE ORDER | 2017-09-12 | −$3,885 | $3,883 | MATULANE (PROCARBAZINE) 50MG |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI XCURRXC2BLG8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24923P0307 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $20,125 | FY2023 |
| 36C25718P0132 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $3,859 | FY2018 |
| VA24517P4538 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $11,498 | FY2017 |
| VA25717P2119 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $3,859 | FY2017 |
| VA25917E5150 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $15,534 | FY2017 |
| VA24617P4378 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · Q517 · MEDICAL- PHARMACOLOGY | $3,884 | FY2017 |
Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0690 | SINA DRUG LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $188,463 | FY2026 |
| 36C24726N0211 | BOSTON SCIENTIFIC CORP | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $248,982 | FY2026 |
| 36C24726F0100 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $228,396 | FY2026 |
| 36C24726F0053 | EXELAN PHARMACEUTICALS INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $4,765,853 | FY2026 |
| 36C24726F0043 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $109,456 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24715P3259_3600_-NONE-_-NONE- · retrieved 2026-09-26.